Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,407 | -6,811 | -17,561 | -5,749 | -13,777 |
| Depreciation Amortization | 605 | 609 | 1,226 | 609 | 1,259 |
| Income taxes - deferred | N/A | -88 | N/A | N/A | N/A |
| Accounts receivable | N/A | 29 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -555 | N/A | N/A | N/A |
| Other Working Capital | -817 | -613 | 6,737 | 539 | 3,099 |
| Other Operating Activity | 5,020 | 1,944 | 3,315 | 473 | -784 |
| Operating Cash Flow | $-8,599 | $-5,486 | $-6,283 | $-4,128 | $-10,203 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 6,345 | N/A | N/A | N/A |
| Other Financing Activity | 10,350 | 0 | 3,925 | 3,097 | 8,733 |
| Financing Cash Flow | $10,350 | $6,345 | $3,925 | $3,097 | $8,733 |
| Exchange Rate Effect | -10 | 57 | 8 | -63 | 43 |
| Beginning Cash Position | 1,073 | 1,080 | 3,437 | 3,415 | 4,956 |
| End Cash Position | 2,814 | 1,996 | 1,087 | 2,321 | 3,528 |
| Net Cash Flow | $1,741 | $917 | $-2,350 | $-1,094 | $-1,427 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,599 | -5,486 | -6,283 | -4,128 | -10,203 |
| Free Cash Flow | -8,599 | -5,486 | -6,283 | -4,128 | -10,203 |